CS logo
small CS logo
UCLA Division of Rheumatology

Los Angeles, California, United States
Rheumatologist in Los Angeles, California
1000 Veteran Ave, Los Angeles, CA 90024

About UCLA Division of Rheumatology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at UCLA Division of Rheumatology


During the past decade, UCLA Division of Rheumatology conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "UCLA Division of Rheumatology" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials, followed by "Celgene" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored, "NYU Langone Health" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Division of Rheumatology" #1 collaborator was "Autoimmunity Centers of Excellence" with 3 trials as a collaborator, "Rho Federal Systems Division, Inc." with 3 trials as a collaborator, "Immune Tolerance Network (ITN)" with 2 trials as a collaborator, "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 2 trials as a collaborator and "Office of Research on Women's Health (ORWH)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

Clinical Trials Conditions at UCLA Division of Rheumatology


According to Clinical.Site data, the most researched conditions in "UCLA Division of Rheumatology" are "Systemic Lupus Erythematosus" (5 trials), "Systemic Sclerosis" (4 trials), "Diffuse Cutaneous Systemic Sclerosis" (3 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Lupus Nephritis" (2 trials). Many other conditions were trialed in "UCLA Division of Rheumatology" in a lesser frequency.

Clinical Trials Intervention Types at UCLA Division of Rheumatology


Most popular intervention types in "UCLA Division of Rheumatology" are "Drug" (16 trials), "Biological" (5 trials), "Other" (2 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "GLPG1690" (2 trials), "1.2% Sodium Hyaluronate" (1 trials), "Acetaminophen" (1 trials) and "Ad26.COV2.S" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UCLA Division of Rheumatology


The vast majority of trials in "UCLA Division of Rheumatology" are 20 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at UCLA Division of Rheumatology


Currently, there are NaN active trials in "UCLA Division of Rheumatology". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in UCLA Division of Rheumatology, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in UCLA Division of Rheumatology, 4 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".